Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Galmed Pharmaceuticals (GLMD) stocks

Learn how to easily invest in Galmed Pharmaceuticals stocks.

Galmed Pharmaceuticals is a biotechnology business based in the US. Galmed Pharmaceuticals stocks (GLMD.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.93 – an increase of 9.52% over the previous week. Galmed Pharmaceuticals employs 19 staff and has a market cap (total outstanding stock value) of $12.1 million.

How to buy stocks in Galmed Pharmaceuticals

  1. Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – GLMD – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Galmed Pharmaceuticals stock price (NASDAQ:GLMD)

Use our graph to track the performance of GLMD stocks over time.

Galmed Pharmaceuticals shares at a glance

Information last updated 2022-06-25.
Latest market close$0.48
52-week range$0.42 - $3.42
50-day moving average $0.82
200-day moving average $1.80
Wall St. target price$4.13
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.19

Compare stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 6 of 6
Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
CIBC Investor's Edge
Finder Rating:
4 / 5
$0 if conditions met, otherwise $100 a year
Stocks, Bonds, Options, Mutual Funds, ETFs
Young investors 18 to 24 can get free online trades and a $0 annual account fee. Conditions apply.
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
Scotia iTRADE
Finder Rating:
3.8 / 5
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get $25 when you open a Wealthsimple Trade account and fund at least $150.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get almost $500 in commission free trades when you fund your new account with a minimum of $10,000. Conditions apply. Ends August 31, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Galmed Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Galmed Pharmaceuticals price performance over time

Historical closes compared with the close of $0.483 from 2022-06-24

1 week (2022-06-17) 9.52%
1 month (2022-05-26) -8.00%
3 months (2022-03-25) -68.22%
6 months (2021-12-23) -76.21%
1 year (2021-06-25) -84.62%
2 years (2020-06-26) -90.34%
3 years (2019-06-26) 6.46
5 years (2017-06-26) 6.02

Galmed Pharmaceuticals financials

Gross profit TTM $0
Return on assets TTM -41.18%
Return on equity TTM -76.83%
Profit margin 0%
Book value $0.97
Market capitalisation $12.1 million

TTM: trailing 12 months

Galmed Pharmaceuticals share dividends

We're not expecting Galmed Pharmaceuticals to pay a dividend over the next 12 months.

Galmed Pharmaceuticals share price volatility

Over the last 12 months, Galmed Pharmaceuticals's shares have ranged in value from as little as $0.417 up to $3.42. A popular way to gauge a stock's volatility is its "beta".

GLMD.US volatility(beta: 1.83)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Galmed Pharmaceuticals's is 1.8253. This would suggest that Galmed Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Galmed Pharmaceuticals overview

Galmed Pharmaceuticals Ltd. , a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. It has a research agreement with Gannex Pharma Co. , Ltd.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site